O&G Cases · Reproductive endocrinology & infertility
Severe Asherman after postpartum curettage — management and counselling station
Management and communication station: severe Asherman after postpartum curettage. Tests the diagnostic pathway, severity grading, hysteroscopic adhesiolysis with a mandatory prevention plan, the evidence for adjuvants (gel, estrogen, barriers), second-look strategy, refractory-disease options, and honest counselling on reproductive prognosis and obstetric surveillance. Includes assessor key and marking domains.
On this page & tools
Target exams
Station brief
Format. Management and communication station, approximately 12 minutes. You are the fertility clinic registrar. A clinic nurse and a counsellor are available; the consultant is contactable. The assessor will play the patient and her partner and feed you their questions and concerns.[1]
Candidate instruction. Establish the diagnosis and severity, plan the hysteroscopic adhesiolysis with a mandatory prevention strategy, sequence the second-look and refractory-disease options, and counsel the couple honestly on reproductive prognosis and obstetric surveillance. Demonstrate the counselling out loud.[1][2]
You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship atlas.
References7Show ledgerHide ledger
- [1]Ma H, Yang M A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions Obstetrical & gynecological survey, 2026.PMID 42241335
- [2]Munro MG, Salazar CA, Bhagavath B, Emanuel MH, Huddleston HG, Sobti D, Jaiswal AK, Gamburg R, Kumar J, Martin C, Hooker AB The epidemiology, clinical burden, and prevention of intrauterine adhesions (IUAs) related to surgically induced endometrial trauma: a systematic literature review and selective meta-analyses Human reproduction update, 2025.PMID 40914965
- [3]Luo Y, Sun Y, Huang B, Chen J, Xu B, Li H Effects and safety of hyaluronic acid gel on intrauterine adhesion and fertility after intrauterine surgery: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials American journal of obstetrics and gynecology, 2024.PMID 38191020
- [4]Feng L, Sun Y, Zhang S, Qian Y, Fang S, Yang B, Xu L, Li J, Niu Y, Zhang S, Zhang L, Chen J A novel intrauterine estrogen-releasing system for preventing the postoperative recurrence of intrauterine adhesion: a multicenter randomized controlled study BMC medicine, 2024.PMID 39285313
- [5]Liu L, Huang X, Xia E, Zhang X, Li TC, Liu Y A cohort study comparing 4 mg and 10 mg daily doses of postoperative oestradiol therapy to prevent adhesion reformation after hysteroscopic adhesiolysis Human fertility (Cambridge, England), 2019.PMID 29504823
- [6]Hooker AB, de Leeuw RA, Twisk JWR, Brölmann HAM, Huirne JAF Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial Human reproduction (Oxford, England), 2021.PMID 33320197
- [7]Hou Z, Yang T, Xu D, Fu J, Tang H, Zhao J, Zhang Q, Chen J, Qin Q, Li W, Chen H, Li H, Guo L, Xu B, Li Y hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial Stem cells translational medicine, 2025.PMID 40371958